Stay updated with breaking news from Diagnostics Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
YORK, England, April 21, 2022 /PRNewswire/ -- Syndromic Multiplex Diagnostics and Panels Markets: Strategies and Trends, Forecasts by Syndrome, Facility, Product and Country with Market Analysis
/PRNewswire/ -- Syndromic Multiplex Diagnostics and Panels Markets: Strategies and Trends, Forecasts by Syndrome, Facility, Product and Country with Market...
An uptick in COVID-19 cases is raising concerns about the forthcoming winter, during which the virus has the potential to survive longer and be more virulent. Furthermore, high travel activity...
Even as the market has remained volatile over the past few months due to rising inflation and a resurgence of COVID-19 cases, some companies have remained relatively stable based on...
Meridian Bioscience receives NIH Award for supporting rapid development of Revogene® molecular test for SARS-CoV-2 CINCINNATI, Dec. 16, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADx SM) initiative, to expedite the launch of the company’s SARS-CoV-2 molecular diagnostic test on the Revogene ® platform. On December 7, the applicatio...